Official UK procurement notice
Purchase of Secukinumab (Cosentyx)
Authority: Belfast Health & Social Care Trust (Central government)
Sectors: Medical Devices & Pharma (33) Delivery: Northern Ireland (UKN)
Awarded value£4,090,000published contract · exc. VAT
Awarded 1 Jun 2021no call for competition
Awarded to Healthcare at Home Ltd
What is being bought
Published requirement descriptionPurchase of Secukinumab (Cosentyx)
CPV: Pharmaceutical products
The lotProcurement structure
single lot · no lot value publishedLot #1Awarded
Procedure terms & legal framework
From the official record- Procedure method
- Award procedure without prior publication of a call for competition
- Legal basis
- CELEX · 32014L0024 Public Contracts Regulations 2015 (Directive 2014/24/EU)
- Procurement category
- Goods
- Notice status
- Awarded without competition
- Procurement threshold
- Unspecified in notice
- Regulatory regime
- Standard
- Commercial structure
- Stand-alone contract (no framework)
- Competition type
- Direct award (no call for competition)
- GPA / WTO covered
- Yes (GPA)
- Recurring procurement
- Unspecified in notice
- First published
- 23 Jun 2021, 11:45 BST
- Last source update
- 23 Jun 2021, 11:45 BST
- Authority reference
DACPM2021-46- FTS notice number
2021/S 000-014292- Classification (CPV)
- Delivery area
- Official registry OCID
ocds-h6vhtk-02bf47Find a Tender
- Why no open competition
The works, supplies or services can be provided only by a particular economic operator due to protection of exclusive rights, including intellectual property rights
- Published justification
Secukinumab (Cosentyx) is a branded patent protected medicine that is only available from Novartis via their homecare provider Healthcare at Home.
Commercial outcome & contract awards
Published awards, contracts and bid statistics, not a forecastAwards 1
Awarded value £4,090,0001 contract exc. VAT
Bids received 1
Contracts signed 1latest 1 Jun 2021
| Awarded to | Value | Date | Status |
|---|---|---|---|
| Healthcare at Home Ltd | £4,090,000 † | — | Awarded |
Contracts
Purchase of Secukinumab (Cosentyx) · Healthcare at Home Ltd
- Signed
- 1 Jun 2021
- Value
- £4,090,000
- Status
- active
Bid statistics published by the authority
| Bids | SME | VCSE | Valid bid range |
|---|---|---|---|
| 1bids | — | — | — |
Contracting authority & participating public bodies
Bidders & participating suppliers
1 commercial party on the notice- Healthcare at HomeAwarded supplier
Official documents & specifications
Official links; attachments are not copiedNo document links were published on the notice.